Dougherty & Co Upgrades Hologic (HOLX) to Buy; Pending GPRO Acquisition
Tweet
Share
E-mailGet Alerts HOLX Hot Sheet
Price: $74.73 -0.25%
Rating Summary:
11 Buy, 18 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 14 | New: 16
Rating Summary:
11 Buy, 18 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 14 | New: 16
Join SI Premium – FREE
Dougherty & Co upgraded Hologic (NASDAQ: HOLX) from Neutral to Buy with a price target of $21.00 (from $20.00).
Analyst, Junaid Husain, said, "Following last night's Q3 results, we're upgrading HOLX to Buy ahead of the pending Aug 1st close of the Gen-Probe (Nasdaq: GRPO) acquisition...Ultimately, our Buy rating is predicated on solid execution of the Gen-Probe transaction."
For an analyst ratings summary and ratings history on Hologic click here. For more ratings news on Hologic click here.
Shares of Hologic closed at $18.26 yesterday.
Analyst, Junaid Husain, said, "Following last night's Q3 results, we're upgrading HOLX to Buy ahead of the pending Aug 1st close of the Gen-Probe (Nasdaq: GRPO) acquisition...Ultimately, our Buy rating is predicated on solid execution of the Gen-Probe transaction."
For an analyst ratings summary and ratings history on Hologic click here. For more ratings news on Hologic click here.
Shares of Hologic closed at $18.26 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cleveland Research Upgrades Dynatrace Inc. (DT) to Buy, 'optimism underlying fundamentals are likely to support upside'
- Stifel Upgrades Oxford Biomedica (OXB:LN) (OXBDF) to Buy
- Telekom Malaysia Bhd (T:MK) (MYTEF) PT Raised to MYR7.30 at Macquarie
Create E-mail Alert Related Categories
Analyst PT Change, Mergers and Acquisitions, UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
